{"id":815,"date":"2026-09-01T19:07:33","date_gmt":"2026-09-01T19:07:33","guid":{"rendered":"https:\/\/nhdbio.com\/resources\/hexarelin-human-dose-response-growth-hormone-evidence\/"},"modified":"2026-09-08T07:30:41","modified_gmt":"2026-09-08T07:30:41","slug":"hexarelin-human-dose-response-growth-hormone-evidence","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/hexarelin-human-dose-response-growth-hormone-evidence\/","title":{"rendered":"Preuve humaine sur l'hexar\u00e9line\u00a0: r\u00e9ponse \u00e0 la dose, pic et limites du GH"},"content":{"rendered":"
Hexarelin a contr\u00f4l\u00e9 les donn\u00e9es pharmacologiques humaines, mais la preuve centrale est une exp\u00e9rience dose-r\u00e9ponse aigu\u00eb 12-personne GH plut\u00f4t qu'un essai de r\u00e9sultat clinique.<\/p>
Les preuves en un coup d'\u0153il<\/h2>
Douze hommes en bonne sant\u00e9 ont re\u00e7u un placebo et de l'hexar\u00e9line intraveineuse 0.5, 1 et 2 \u00b5g\/kg dans une \u00e9tude en double aveugle \u00e0 dose croissante.<\/li>
Le pic moyen de GH \u00e9tait de 3.9, 26.9, 52.3 et 55.0 ng\/mL, avec un plateau de r\u00e9ponse entre 1 et 2 \u00b5g\/kg.<\/li>
GH a culmin\u00e9 \u00e0 environ 30 minutes, est revenu \u00e0 la ligne de base en quelques minutes 240 et avait une demi-vie estim\u00e9e proche de 55 minutes.<\/li><\/ul><\/div><\/div>Illustration \u00e9ditoriale g\u00e9n\u00e9r\u00e9e par AI illustrant le flux de travail de recherche. Il ne s\u2019agit pas d\u2019une figure d\u2019\u00e9tude, d\u2019une image de patient, d\u2019une photographie de produit, d\u2019un r\u00e9sultat d\u2019analyse ou d\u2019un lot de catalogue.<\/figcaption><\/figure>
Dossier d'\u00e9tudes<\/h2>
L'\u00e9tude 1994 a ins\u00e9r\u00e9 un placebo de mani\u00e8re al\u00e9atoire dans la s\u00e9quence de doses croissantes. Les pics moyens presque identiques \u00e0 1 et 2 \u00b5g\/kg constituent un r\u00e9sultat de plateau utile et ne doivent pas \u00eatre r\u00e9\u00e9crits sous la forme \u00ab plus haut est toujours mieux \u00bb.<\/p>
Participants<\/strong>12 hommes adultes en bonne sant\u00e9<\/span><\/div>
Conception<\/strong>En double aveugle, contr\u00f4l\u00e9 par placebo, \u00e0 dose croissante<\/span><\/div>
Moyenne GH Cmax<\/strong>3.9, 26.9, 52.3 et 55.0 ng\/mL<\/span><\/div>
Estimation ED50<\/strong>0.50 \u00b5g\/kg par Cmax\u00a0; 0.64 \u00b5g\/kg par AUC<\/span><\/div>
Limite du r\u00e9sultat<\/strong>Lib\u00e9ration aigu\u00eb d'hormones, et non b\u00e9n\u00e9fice en mati\u00e8re de maladie, de long\u00e9vit\u00e9 ou de performance<\/span><\/div><\/div><\/div>
R\u00e9sultats en contexte<\/h2>
Une \u00e9tude ult\u00e9rieure men\u00e9e aupr\u00e8s de six personnes a compar\u00e9 deux \u00e0 trois administrations sous-cutan\u00e9es quotidiennes tout en surveillant GH, la prolactine, ACTH et le cortisol pendant des heures 24. De multiples changements endocriniens renforcent le fait que Hexarelin ne peut pas \u00eatre r\u00e9duit \u00e0 une all\u00e9gation s\u00e9lective uniquement GH.<\/p>
WADA r\u00e9pertorie Examorelin\/Hexarelin parmi les peptides interdits lib\u00e9rant du GH. Cette classification est pertinente pour le sport mais n\u2019\u00e9tablit pas l\u2019efficacit\u00e9 ou l\u2019identit\u00e9 du produit.<\/p>
Ce que la preuve ne peut \u00e9tablir<\/h2>
L'essai principal portait sur des participants masculins en bonne sant\u00e9 12 et pr\u00e9sentait des crit\u00e8res d'\u00e9valuation aigus.<\/p>
Aucun r\u00e9sultat concernant la composition corporelle, la r\u00e9cup\u00e9ration, la maladie ou la s\u00e9curit\u00e9 \u00e0 long terme n\u2019a \u00e9t\u00e9 mesur\u00e9.<\/p>
La r\u00e9ponse endocrinienne d'un mat\u00e9riel exp\u00e9rimental d\u00e9fini ne peut pas valider un lot du catalogue.<\/p>","protected":false},"excerpt":{"rendered":"
Hexarelin a contr\u00f4l\u00e9 les donn\u00e9es pharmacologiques humaines, mais la preuve centrale est une exp\u00e9rience dose-r\u00e9ponse aigu\u00eb 12-personne GH plut\u00f4t qu'un essai de r\u00e9sultat clinique.<\/p>","protected":false},"author":1,"featured_media":799,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"336","pim_article_type":"Published evidence review","pim_evidence_level":"Double-blind 12-person dose-response trial plus small repeated-exposure physiology study","pim_reviewer":"Site evidence editorial team","pim_reviewed_date":"2026-09-02","pim_editorial_note":"Source-checked on 2026-09-02. Null results, sample size, model\/population limits, finished-drug scope, regulatory status and product-evidence boundaries are retained. This is not medical advice, a customer case or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"Primary and official sources, numerical results, null findings, limitations, product-evidence boundary and image disclosure checked for batch 5.","pim_creation_method":"This article discusses the source records listed below, with the study models and limitations stated alongside the findings. AI-assisted drafting and image generation were used. The reference list identifies the records behind this article; it is not an independent peer review or verification of a supplied catalog lot.","pim_sources":"[{\"title\":\"Hexarelin human dose-response study\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/7957536\/\",\"note\":\"Double-blind 12-person study; PMID 7957536.\"},{\"title\":\"Repeated Hexarelin administration in healthy men\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/11888836\/\",\"note\":\"Six-person 24-hour endocrine study; PMID 11888836.\"},{\"title\":\"PubChem Examorelin record\",\"url\":\"https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Examorelin\",\"note\":\"Sequence, formula, molecular weight and synonyms; CID 6918297.\"},{\"title\":\"WADA 2026 Prohibited List\",\"url\":\"https:\/\/www.wada-ama.org\/sites\/default\/files\/2025-09\/2026list_en_final_clean_september_2025.pdf\",\"note\":\"Official list includes Examorelin\/Hexarelin.\"}]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-815","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\n
Hexarelin Human Evidence: Dose Response, GH Peak and Limits<\/title>\n<meta name=\"description\" content=\"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/hexarelin-human-dose-response-growth-hormone-evidence\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\" \/>\n<meta property=\"og:description\" content=\"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/hexarelin-human-dose-response-growth-hormone-evidence\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-01T19:07:33+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-08T07:30:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\",\"datePublished\":\"2026-09-01T19:07:33+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\"},\"wordCount\":270,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\",\"name\":\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"datePublished\":\"2026-09-01T19:07:33+00:00\",\"dateModified\":\"2026-09-08T07:30:41+00:00\",\"description\":\"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/hexarelin-evidence.webp\",\"width\":1536,\"height\":1024,\"caption\":\"AI-generated illustration: clinical pharmacology laboratory for a Hexarelin evidence review\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/hexarelin-human-dose-response-growth-hormone-evidence\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hexarelin Human Evidence: Dose Response, GH Peak and Limits\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Preuve humaine sur l'hexar\u00e9line\u00a0: r\u00e9ponse \u00e0 la dose, pic et limites du GH","description":"Hexarelin a contr\u00f4l\u00e9 les donn\u00e9es pharmacologiques humaines, mais la preuve centrale est une exp\u00e9rience dose-r\u00e9ponse aigu\u00eb 12-personne GH plut\u00f4t qu'un r\u00e9sultat clinique\u2026","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/hexarelin-human-dose-response-growth-hormone-evidence\/","og_locale":"fr_FR","og_type":"article","og_title":"Hexarelin Human Evidence: Dose Response, GH Peak and Limits","og_description":"Hexarelin has controlled human pharmacology data, but the central evidence is an acute 12-person GH dose-response experiment rather than a clinical-outcome\u2026","og_url":"https:\/\/nhdbio.com\/fr\/hexarelin-human-dose-response-growth-hormone-evidence\/","og_site_name":"NHD","article_published_time":"2026-09-01T19:07:33+00:00","article_modified_time":"2026-09-08T07:30:41+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"Hexarelin Human Evidence: Dose Response, GH Peak and Limits","datePublished":"2026-09-01T19:07:33+00:00","dateModified":"2026-09-08T07:30:41+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/"},"wordCount":270,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","articleSection":["Published Study Reviews"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/","url":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/","name":"Preuve humaine sur l'hexar\u00e9line\u00a0: r\u00e9ponse \u00e0 la dose, pic et limites du GH","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","datePublished":"2026-09-01T19:07:33+00:00","dateModified":"2026-09-08T07:30:41+00:00","description":"Hexarelin a contr\u00f4l\u00e9 les donn\u00e9es pharmacologiques humaines, mais la preuve centrale est une exp\u00e9rience dose-r\u00e9ponse aigu\u00eb 12-personne GH plut\u00f4t qu'un r\u00e9sultat clinique\u2026","breadcrumb":{"@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp","width":1536,"height":1024,"caption":"AI-generated illustration: clinical pharmacology laboratory for a Hexarelin evidence review"},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/hexarelin-human-dose-response-growth-hormone-evidence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"Hexarelin Human Evidence: Dose Response, GH Peak and Limits"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=815"}],"version-history":[{"count":2,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/815\/revisions"}],"predecessor-version":[{"id":1188,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/815\/revisions\/1188"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/799"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
![\"Laboratoire](\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/hexarelin-evidence.webp\")